Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

China

 

Chinese private equity hesitantly entering elderly care

Hong Kong-listed investment group China Everbright Ltd. is buying Beijing Huichen Nursing Home Management as part of its Healthcare Fund I. Xiaoyin Shen from Everbright's healthcare division told Healthcare Nova that investors are starting look at elderly care platforms in China as the government takes steps to liberalize the sector.

Fosun Property eyes elderly care JVs

As Western companies are starting to doubt the promises of China's elderly care market, we hear Fosun Property, the real estate division of conglomerate Fosun, is looking to invest into European nursing homes.

China – a fabled land for elderly care?

We are hearing grunts of disillusionment with the Chinese elderly care market from European operators who have examined it seriously. They say there is no goldrush.

The cost of getting culture wrong in long-term care

Cultural issues are at the forefront of the difficulties in running and investing into long-term care in emerging markets. At the Healthcare Business International 2016 conference, the CEOs of Senior Assist, Belgium’s third largest care home operator and a player in Latin America and Turkey, and TVM Capital, a private equity firm investing in rehabilitation in the Middle East, shared their views on the sector.

FREE BLOG Chinese hospitals look abroad for expertise

As Luye Medical Group, part of the $2.5bn Hong Kong-listed pharma giant Luye Pharma, spends $700m on Australia’s third largest hospital operator to help ‘designing and managing Chinese hospitals’, it is clear that the Chinese healthcare industry is looking to Westernise. But the country is still a difficult market to enter.

Chinese operator spends $700m in Australia

Healthe Care, Australia’s third largest hospital operator, sold to Chinese provider Luye Medical Group for $700m (A$938m). Luye aims to import Healthe Care’s management expertise to China and is planning a $234m (A$300m) hospital expansion plan in Australia.

Rating and booking sites: Threats or Friends?

There are growing signs that a new generation of rating and booking websites will change the face of outpatient care in many Emerging Markets. New players, sometimes backed by hundreds of millions of dollars, are investing in telehealth platforms that promise instant access to patients, partnering with pharmacies and making access to healthcare easier for patients. Some are active in dozens of countries. Here we talk to the major players about their strategies and how they see the market.

So what really happened at Bupa?

After four years, in which he transformed Bupa with a £1.8bn M&A drive, the company announced that CEO Stuart Fletcher is to leave after failing to meet expectations. His departure follows 2015 results which saw a fall of pre-tax profits of 39% to £347m. Where does that leave his plans to build an international brand with strengths in services as well as insurance? What really went wrong? With 2015 sales of £9.8bn, Bupa still has heft. Outside the USA, it remains one of the two largest international private medical insurers, the largest international dentistry player, one of the largest care home groups and, probably, the largest player in outpatient care – certainly the only one with scale in four continents.

Bain buys Chinese hospital group

Private equity house Bain Capital has bought Chinese hospital group Asia Pacific Medical (APM) for $150m, according to press reports. The deal marks Bain's entry to China after raising $3bn for its Asia fund in December 2015.

Find Us